ロード中...
Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges
Novel therapies are challenging the standards of drug development. Agents with specific biologic targets, unknown dose-efficacy curves, and limited toxicity mandate novel designs to identify biologically optimal doses. We review two model-based designs that utilize either a proportional odds model o...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931331/ https://ncbi.nlm.nih.gov/pubmed/20419760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.3706 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|